Tudor Investment Corp’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Hold |
225,186
| – | – | ﹤0.01% | 1093 |
|
|
2025
Q1 | $1.24M | Sell |
225,186
-80,000
| -26% | -$439K | ﹤0.01% | 958 |
|
|
2024
Q4 | $1.03M | Sell |
305,186
-202,171
| -40% | -$685K | ﹤0.01% | 995 |
|
|
2024
Q3 | $1.45M | Sell |
507,357
-65,829
| -11% | -$188K | 0.01% | 893 |
|
|
2024
Q2 | $1.29M | Hold |
573,186
| – | – | 0.01% | 891 |
|
|
2024
Q1 | $1.27M | Buy |
573,186
+19,775
| +4% | +$43.7K | 0.01% | 812 |
|
|
2023
Q4 | $1.3M | Sell |
553,411
-88,087
| -14% | -$207K | 0.01% | 854 |
|
|
2023
Q3 | $1.19M | Sell |
641,498
-216,913
| -25% | -$403K | 0.01% | 842 |
|
|
2023
Q2 | $2.25M | Sell |
858,411
-101,700
| -11% | -$266K | 0.03% | 619 |
|
|
2023
Q1 | $1.57M | Hold |
960,111
| – | – | 0.02% | 731 |
|
|
2022
Q4 | $1.28M | Hold |
960,111
| – | – | 0.03% | 742 |
|
|
2022
Q3 | $1.5M | Hold |
960,111
| – | – | 0.03% | 624 |
|
|
2022
Q2 | $1.48M | Sell |
960,111
-1,081
| -0.1% | -$1.67K | 0.04% | 624 |
|
|
2022
Q1 | $2.46M | Buy |
961,192
+1,081
| +0.1% | +$2.77K | 0.06% | 439 |
|
|
2021
Q4 | $2.81M | Buy |
+960,111
| New | +$2.81M | 0.05% | 453 |
|